Teza Capital Management LLC Myriad Genetics Inc Transaction History

Teza Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Feb 22, 2024	BUY	$17.56 - $23.76 $171,490 - $232,040	9,766 New	9,766 $226,000
Q2 2023 Aug 14, 2023	BUY	$17.56 - $23.76 $253,355 - $342,809	14,428 New	14,428 $334,000
Q4 2020 Feb 12, 2021	SELL	$12.16 - $19.77 $160,645 - $261,181	-13,211 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$11.25 - $14.75 $148,623 - $194,862	13,211 New	13,211 $172,000
Q2 2018 Aug 14, 2018	SELL	$27.75 - $40.17 $570,512 - $825,855	-20,559 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$28.83 - $41.01 $65,876 - $93,707	-2,285 Reduced 10.0%	20,559 $608,000
Q4 2017 Aug 14, 2018	BUY	$28.45 - $37.14 $82,846 - $108,151	2,912 Added 14.61%	22,844 $785,000
Q4 2017 Feb 14, 2018	BUY	$28.45 - $37.14 $567,065 - $740,274	19,932	19,932 $685,000

253

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.23B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Teza Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Teza Capital Management LLC with notifications on news.